• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: KANEKA CORPORATION LACRIFAST; LACRIMAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

KANEKA CORPORATION LACRIFAST; LACRIMAL STENT Back to Search Results
Catalog Number LF2-R090
Device Problems Material Puncture/Hole (1504); Material Separation (1562); Use of Device Problem (1670); Device Handling Problem (3265)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 07/27/2016
Event Type  malfunction  
Manufacturer Narrative
The concerned device "lacrifast" is not distributed in us under this device name, but is identical to the device "lacriflow lacrimal stent" distributed in us under 510(k) # k120886.The actual device used was returned and investigated:the stainless steel ring mounted in the tip of the colored in blue tube was dismounted and missing.Accordingly, the missing stainless steel ring might have been remaining in the patient body.The ring's whereabouts was not confirmed during the procedure in this eye clinic.As a possible cause of the penetration of the bougie and dropping off the ring during the use, we speculate as follows: when the doctor tried to insert and advance the tube with the bougie inserted forcibly in the occluded lacrimal duct, excessive mechanical force was loaded on the ring and the distal tip of the tube where the ring was mounted, and further pushing the bougie resulted in dismounting the ring and penetration of the bougie with the ring out of the tube.This report is delayed because it was sent to the emdr test instead of production.
 
Event Description
This device (lacrifast) was employed to treat the epiphora due to lacrimal duct obstruction of (b)(6) patient.The doctor inserted one of the lacrimal duct tube (colored in clear) into the lacrimal duct by dsi (direct silicone intubation) technique.While advancing the tube, the doctor felt that the bougie penetrated out of the tube and retrieved it out of the patient's lacrimal duct.He used another lacrifast and completed the operation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LACRIFAST
Type of Device
LACRIMAL STENT
Manufacturer (Section D)
KANEKA CORPORATION
2-3-18
nakanoshima, kita-ku,
osaka, osaka 530-8 288
JA  530-8288
Manufacturer Contact
kazuhiko inoue
2-3-18
nakanoshima,kita-ku
osaka-city, osaka 530-8-288
JA   530-8288
4613072
MDR Report Key6203740
MDR Text Key63262517
Report Number9614654-2016-00019
Device Sequence Number1
Product Code OKS
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 07/29/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/25/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2019
Device Catalogue NumberLF2-R090
Device Lot NumberKP036514
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/05/2016
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/29/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/18/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age90 YR
-
-